Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1984 1
1985 3
1987 3
1988 2
1989 2
1990 14
1991 34
1992 37
1993 39
1994 41
1995 42
1996 43
1997 41
1998 16
1999 16
2000 13
2001 24
2002 38
2003 41
2004 51
2005 33
2006 32
2007 32
2008 24
2009 20
2010 28
2011 30
2012 39
2013 48
2014 28
2015 30
2016 23
2017 39
2018 41
2019 36
2020 30
2021 23
2022 8
2023 1
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

982 results

Results by year

Filters applied: . Clear all
Page 1
Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease.
Waxman A, Restrepo-Jaramillo R, Thenappan T, Ravichandran A, Engel P, Bajwa A, Allen R, Feldman J, Argula R, Smith P, Rollins K, Deng C, Peterson L, Bell H, Tapson V, Nathan SD. Waxman A, et al. N Engl J Med. 2021 Jan 28;384(4):325-334. doi: 10.1056/NEJMoa2008470. Epub 2021 Jan 13. N Engl J Med. 2021. PMID: 33440084 Clinical Trial.
Inhaled treprostinil and forced vital capacity in patients with interstitial lung disease and associated pulmonary hypertension: a post-hoc analysis of the INCREASE study.
Nathan SD, Waxman A, Rajagopal S, Case A, Johri S, DuBrock H, De La Zerda DJ, Sahay S, King C, Melendres-Groves L, Smith P, Shen E, Edwards LD, Nelsen A, Tapson VF. Nathan SD, et al. Lancet Respir Med. 2021 Nov;9(11):1266-1274. doi: 10.1016/S2213-2600(21)00165-X. Epub 2021 Jun 29. Lancet Respir Med. 2021. PMID: 34214475 Clinical Trial.
Combination Therapy with Oral Treprostinil for Pulmonary Arterial Hypertension. A Double-Blind Placebo-controlled Clinical Trial.
White RJ, Jerjes-Sanchez C, Bohns Meyer GM, Pulido T, Sepulveda P, Wang KY, Grünig E, Hiremath S, Yu Z, Gangcheng Z, Yip WLJ, Zhang S, Khan A, Deng CQ, Grover R, Tapson VF; FREEDOM-EV Investigators. White RJ, et al. Am J Respir Crit Care Med. 2020 Mar 15;201(6):707-717. doi: 10.1164/rccm.201908-1640OC. Am J Respir Crit Care Med. 2020. PMID: 31765604 Free PMC article. Clinical Trial.
Inhaled treprostinil: a therapeutic review.
Channick RN, Voswinckel R, Rubin LJ. Channick RN, et al. Drug Des Devel Ther. 2012;6:19-28. doi: 10.2147/DDDT.S19281. Epub 2012 Jan 24. Drug Des Devel Ther. 2012. PMID: 22291467 Free PMC article. Review.
Treprostinil for pulmonary hypertension.
Skoro-Sajer N, Lang I, Naeije R. Skoro-Sajer N, et al. Vasc Health Risk Manag. 2008;4(3):507-13. doi: 10.2147/vhrm.s2477. Vasc Health Risk Manag. 2008. PMID: 18827901 Free PMC article. Review.
Treprostinil for pulmonary hypertension.
Vachiéry JL, Naeije R. Vachiéry JL, et al. Expert Rev Cardiovasc Ther. 2004 Mar;2(2):183-91. doi: 10.1586/14779072.2.2.183. Expert Rev Cardiovasc Ther. 2004. PMID: 15151467 Review.
982 results